Roles of STAT3 in the pathogenesis and treatment of glioblastoma
Frontiers in Cell and Developmental Biology · 27.02.2023 · 11
DOI: 10.3389/fcell.2023.1098482 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Cell and Developmental Biology, online erschienen am 27.02.2023. Verfasst von Weijia Fu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology & Therapy, The First Hospital of Jilin University, Changchun, China. Die Arbeit wurde bisher 90-mal zitiert (Crossref) und nennt 146 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Jilin Scientific and Technological Development Program.
Abstract (Originalsprache)
Glioblastoma (GBM) is the most malignant of astrocytomas mainly involving the cerebral hemispheres and the cerebral cortex. It is one of the fatal and refractory solid tumors, with a 5-year survival rate of merely 5% among the adults. IL6/JAK/STAT3 is an important signaling pathway involved in the pathogenesis and progression of GBM. The expression of STAT3 in GBM tissues is substantially higher than that of normal brain cells. The abnormal activation of STAT3 renders the tumor microenvironment of GBM immunosuppression. Besides, blocking the STAT3 pathway can effectively inhibit the growth and metastasis of GBM. On this basis, inhibition of STAT3 may be a new therapeutic approach for GBM, and the combination of STAT3 targeted therapy and conventional therapies may improve the current status of GBM treatment. This review summarized the roles of STAT3 in the pathogenesis of GBM and the feasibility of STAT3 for GBM target therapy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiation Oncology & Therapy, The First Hospital of Jilin University, Changchun, China.
- Jilin Provincial Key Laboratory of Radiation Oncology & Therapy, The First Hospital of Jilin University, Changchun, China.
- NHC Key Laboratory of Radiobiology, School of Public Health, Jilin University, Changchun, China.
Förderung
- Jilin Scientific and Technological Development Program
Zitieren
APA
Fu, W., Hou, X., Dong, L., & Hou, W. (2023). Roles of STAT3 in the pathogenesis and treatment of glioblastoma. Frontiers in Cell and Developmental Biology, 11. https://doi.org/10.3389/fcell.2023.1098482
Vancouver
Fu W, Hou X, Dong L, Hou W. Roles of STAT3 in the pathogenesis and treatment of glioblastoma. Frontiers in Cell and Developmental Biology. 2023;11. doi:10.3389/fcell.2023.1098482
BibTeX
@article{Fu2023,
author = {Fu, Weijia and Hou, Xue and Dong, Lihua and Hou, Wei},
title = {Roles of STAT3 in the pathogenesis and treatment of glioblastoma},
journal = {Frontiers in Cell and Developmental Biology},
year = {2023},
volume = {11},
doi = {10.3389/fcell.2023.1098482}
}
EUVIMED